1. Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer’s disease;Shaw;Alzheimers Dement,2018
2. Appropriate use criteria for amyloid PET: a report of the amyloid imaging task force, the society of nuclear medicine and molecular imaging, and the Alzheimer's association;Johnson;Alzheimers Dement,2013
3. Blood-based biomarkers for Alzheimer's disease: towards clinical implementation;Teunissen;Lancet Neurol,2022
4. Lecanemab in early Alzheimer's disease;van Dyck;N Engl J Med,2022
5. Donanemab in early symptomatic alzheimer disease the TRAILBLAZER-ALZ 2 randomized clinical trial;Sims;JAMA,2023